Michael A. Matthay
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Michael A. Matthay sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Michael A. Matthay: 3 sponsored US clinical trials, none currently recruiting.
Michael A. Matthay sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acute Respiratory Distress Syndrome, with 1 trials.
Upper-quartile sponsor footprint
Michael A. Matthay sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
NCT03818854
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)
NCT02097641
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome
NCT01775774
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Therapeutic Areas
How the Michael A. Matthay early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Acute Respiratory Distress Syndrome (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Michael A. Matthay: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Michael A. Matthay sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Michael A. Matthay page
3 registered trials is a research-attention snapshot, not an endorsement of Michael A. Matthay or any single study.
- None of Michael A. Matthay's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Acute Respiratory Distress Syndrome is the condition Michael A. Matthay studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Respiratory Distress Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Michael A. Matthay pipeline card: 3 registered trials from official public datasets.Report a data error.